Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. The company is headquartered in Budapest, Budapest. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
1,609,163
928,962
857,545
805,158
802,755
630,595
Revenue Growth (YoY)
88%
8%
7%
0%
27%
11%
Cost of Revenue
500,565
288,051
280,860
283,834
342,291
281,322
Gross Profit
1,108,598
640,911
576,685
521,324
460,464
349,273
Selling, General & Admin
393,310
222,791
220,991
196,619
182,350
143,261
Research & Development
159,513
91,185
99,250
78,344
75,109
61,005
Operating Expenses
616,844
350,182
333,622
332,104
319,096
208,096
Other Non Operating Income (Expenses)
--
--
-1,386
-280
903
38
Pretax Income
481,905
284,747
281,077
171,540
165,663
146,575
Income Tax Expense
86,127
52,519
41,553
10,889
-5,087
5,395
Net Income
395,660
232,335
239,244
158,850
169,076
139,626
Net Income Growth
65%
-3%
51%
-6%
21%
33%
Shares Outstanding (Diluted)
182.79
182.79
183.01
184.76
186.33
186
Shares Change (YoY)
-1%
0%
-1%
-1%
0%
0%
EPS (Diluted)
2,164.47
1,271
1,307.23
859.72
907.39
750.65
EPS Growth
66%
-3%
52%
-5%
21%
33%
Free Cash Flow
209,999
209,999
191,565
3,900
114,417
-3,393
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
68.89%
68.99%
67.24%
64.74%
57.36%
55.38%
Operating Margin
30.55%
31.29%
28.34%
23.5%
17.61%
22.38%
Profit Margin
24.58%
25.01%
27.89%
19.72%
21.06%
22.14%
Free Cash Flow Margin
13.05%
22.6%
22.33%
0.48%
14.25%
-0.53%
EBITDA
552,217
351,192
292,584
240,028
189,937
186,099
EBITDA Margin
34.31%
37.8%
34.11%
29.81%
23.66%
29.51%
D&A For EBITDA
60,463
60,463
49,521
50,808
48,569
44,922
EBIT
491,754
290,729
243,063
189,220
141,368
141,177
EBIT Margin
30.55%
31.29%
28.34%
23.5%
17.61%
22.38%
Effective Tax Rate
17.87%
18.44%
14.78%
6.34%
-3.07%
3.68%
Follow-Up Questions
What are Gedeon Richter PLC's key financial statements?
According to the latest financial statement (Form-10K), Gedeon Richter PLC has a total asset of $0, Net profit of $232,335
What are the key financial ratios for RGEDF?
Gedeon Richter PLC's Current ratio is 0, has a Net margin is 25.01, sales per share of $5,081.93.
How is Gedeon Richter PLC's revenue broken down by segment or geography?
Gedeon Richter PLC largest revenue segment is Women's Healthcare, at a revenue of 255,673,000,000 in the most earnings release.For geography, United States is the primary market for Gedeon Richter PLC, at a revenue of 216,824,000,000.
Is Gedeon Richter PLC profitable?
yes, according to the latest financial statements, Gedeon Richter PLC has a net profit of $232,335
Does Gedeon Richter PLC have any liabilities?
no, Gedeon Richter PLC has liability of 0
How many outstanding shares for Gedeon Richter PLC?
Gedeon Richter PLC has a total outstanding shares of 0